Clinical trial
Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
NCT07621289 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
- Lead sponsor
- University Hospital, Caen
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- June 22, 2026
- Completion date
- December 31, 2030
- Enrollment
- 10,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anticancer treatment, cancer, cardiovascular disease risk factor, cardiovascular diseases, hematological malignancies